Algisyl Cardiac Implantable Hydrogel and MyoTEC System for percutaneous administration

A new approach for the treatment of heart failureOne time procedure with lasting benefitsNo batteries or mechanical parts that require monitoringNo interference with other devices, drugs, or proceduresGrowing evidence of significant clinical efficacy

Algisyl® provides a new treatment option for patients whose heart is losing the ability to pump sufficient oxygen-rich blood to the body. Algisyl® is a patented gel sourced from marine algae that is injected into specific areas of the weakened and stretched muscle of the heart. The gel reshapes and thickens the wall leading to a reduction of muscle tension and more efficient use of oxygen. The resulting improvement in cardiac function supports an increase in exercise capacity, clinical status, and quality of life.

For more information, watch our video and continue reading in the pages linked above.

CAUTION: Investigational device. Limited by United States law to investigational use only.